Tezepelumab Increases Probability Of SNOT-22 Low Disease Severity Scores Among Patients With CRSwNP (WAYPOINT)

Journal of Allergy and Clinical Immunology 2026

View at publisher

Authors: Joseph K. Han, Claire L Hopkins, Sarah Wise, Claudia Chen, Andrew Foster, Andrew Lindsley, Chris Ambrose

DOI: 10.1016/j.jaci.2025.12.246

Cited by: 0

Fields of Study & Subjects

Sinusitis and nasal conditions Cystic Fibrosis Research Advances Asthma and respiratory diseases